Closing Bell: Nervgen Pharma Corp up on Thursday (NGEN)

Nervgen Pharma Corp opened trading today at $3.10 and closed at $3.20. Intraday prices ranged from a low of $3.05 to a high of $3.25.

The price raised 5.26% from the previous day's close of $3.04.

During the day across North America, the TSX Composite closed 0.09% at 22244.02, the S&P 500 closed 0.51% at 5537.02, the Dow Jones Industrial Average closed -0.06% at 39308.00 and the Nasdaq Composite closed 0.88% at 18188.30.

Nervgen Pharma Corp has listed on the Toronto Venture Exchange (TSX-V) under the ticker NGEN.

A total of 68,744 shares was traded during the last trading day, with total trades of 116, with an average volume of 106,452 in the last five days.

Trading across the entire TSX-V saw 2,923 price advancers against 2,213 declines and 180 unchanged.

During the prior 52 weeks, NGEN.VN has traded as high as $3.98 (February 05,2024) and low as $1.58 (December 14,2023). Moreover, in the last 52 weeks, Nervgen Pharma Corp's shares have surged 82.86 percent, while in 2024, they have boosted 18.52%.

Following today's trading, Nervgen Pharma Corp has a market capitalization of $212.58 million on a float of 69,928 shares outstanding. Its annual EPS is $-0.34.

Nervgen Pharma Corp is a TSX Biotechnology company headquartered in Vancouver, CAN.

Currently, Nervgen Pharma Corp's consensus rating is "Strong Sell" based on 0 analysts according to Zacks. Currently, there are for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..